AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Cholangiocarcinoma

Open on HERB 2.0 ↗
8
Clinical Trials
2
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT04264260
Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment
Recruiting · Phase 2
NCT05506943
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
Active_Not_Recruiting · Phase 2|Phase 3
NCT05823311
Lenvatinib, Tislelizumab Combined With Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
Recruiting · Phase 3
📊 Sample Meta-Analyses
CRD42019123716
Comparison between fluoropyrimidine-cisplatin and gemcitabine-cisplatin as first-line chemotherapy for advanced biliary tract cancer: a meta-analysis
Advanced biliary tract cancer (cholangiocarcinoma or gallbladder cancer)
CRD42021276554
Effect of Ursodeoxycholic Acid on development of Cholangiocarcinoma in patients with Primary Sclerosing Cholangitis: A Systematic Review
Cholangiocarcinoma in patients with Primary Sclerosing Cholangitis
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Cholangiocarcinoma
🏥 Names
Disease Name
Cholangiocarcinoma
Alias Names
Intrahepatic Cholangiocarcinoma; Cholangiocarcinoma; Bile Duct Carcinoma; Extrahepatic Cholangiocarcinoma; Bile Duct Cancer; Bile Duct Adenocarcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Neoplasms
HPO Class
Neoplasm; Abnormality of the digestive system
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
HERB DB
HBDIS004428 ↗
MeSH
D018281 ↗
HPO
HP:0030153 ↗
Disease Ontology
4896; 4897; 4928; 4947
DisGeNET
C0206698
🔍 Raw view — every non-empty column on this row (29 fields)
name
Cholangiocarcinoma
alias name
Intrahepatic Cholangiocarcinoma; Cholangiocarcinoma; Bile Duct Carcinoma; Extrahepatic Cholangiocarcinoma; Bile Duct Cancer; Bile Duct Adenocarcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Neoplasms
hpo disease class
Neoplasm; Abnormality of the digestive system
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04
hpo disease class id
HP:0025031; HP:0002664
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS004428
disgenet id
C0206698
mesh id
D018281
hpo id
HP:0030153
do id
4896; 4897; 4928; 4947

⚗️ Related Ingredients

3 · shared evidence
Cisplatin
Colchicine
Taxol

📋 Clinical Trials

8 · subject of clinical study
NCT04264260 Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tum
→ Hepatocellular Carcinoma Stage IIIB|Cholangiocarci
NCT05506943 A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresec
→ Biliary Tract Cancer|Cholangiocarcinoma|Gall Bladd
NCT05823311 Lenvatinib, Tislelizumab Combined With Gemcitabine and Cisplatin (GPLET) in the
→ Advanced Cholangiocarcinoma
NCT05738057 Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Ad
→ Unresectable Intrahepatic Cholangiocarcinoma
NCT05967182 A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperat
→ Cholangiocarcinoma
NCT06048133 Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of
→ Biliary Tract Carcinoma|Cholangiocarcinoma|Bile Du
NCT06037980 CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy
→ Biliary Tract Cancer|Cholangiocarcinoma
NCT05978609 Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
→ Cholangiocarcinoma Non-resectable

📊 Meta-Analyses

2 · systematic review
CRD42019123716 Comparison between fluoropyrimidine-cisplatin and gemcitabine-cisplatin as first
→ Advanced biliary tract cancer (cholangiocarcinoma
CRD42021276554 Effect of Ursodeoxycholic Acid on development of Cholangiocarcinoma in patients
→ Cholangiocarcinoma in patients with Primary Sclero
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables